The inquiry was established to identify solutions to blockages that affect the ability of the scientific and clinical communities to advance options for, and the outcomes of, those affected by this devastating disease.
We are pleased to be sitting on the panel for this inquiry, represented by our Chief Scientific Officer Dr David Jenkinson, alongside our colleagues at charity Brain Tumour Research, Parliamentarians, patient representatives and expert clinicians and researchers.
Today’s session included presentations from Dr Nicky Huskens at the Tessa Jowell Brain Cancer Mission (TJBCM), sharing evidence they have gathered from the Centre of Excellence applications regarding research at their Centres, and from the National Cancer Research Institute (NCRI) brain cancer group reflecting on the last five years, on the current funding landscape and on what they believe needs to happen from a joined-up funding perspective to accelerate greater progress.
The Chair of the APPGBT, Derek Thomas MP, led fellow Parliamentarians and the panel to ask questions of those presenting evidence.
Further evidence will be gathered in written form and at oral evidence sessions attended by researchers, clinicians, funders, industry, and patients over the coming months, ahead of the publication of a report from the inquiry in early 2023.